Xeris Pharmaceuticals, Inc.

Today marks a meaningful milestone for our company: 10 years since FDA approval of KEVEYIS® (dichlorphenamide). Our mission has always been to improve the lives of patients living with rare diseases and underserved conditions. This anniversary is more than a product milestone – it’s a reflection of our ongoing commitment to patient outcomes, our continued investment in #RareDisease support, and the strong partnerships we’ve built within this community. To patients, caregivers, healthcare providers, and advocates, thank you for your trust, collaboration, and resilience. We remain steadfast in our dedication to supporting you on your journey. #KEVEYIS10

We’re proud to celebrate our team following our successful presence at #AACE2025 in May! Our passion for excellence and cross-functional #Teamwork reflects how we live our core values at Xeris, and every detail, from scientific presentations to booth engagement, was a testament to the dedication, #Collaboration, and expertise of our amazing team. A heartfelt thank you to everyone across the organization who contributed. Your flexibility, commitment, and seamless teamwork brought our mission to life and made a meaningful impact on the conference floor. #LivingOurValues #CompanyCulture #PurposeDriven

What an incredible week surrounded by some of the most inspiring individuals and families in the #Diabetes community! Attending Children With Diabetes Friends for Life Orlando 2025 was an unforgettable experience for our team. Over the course of several days, we had the privilege of connecting with families, children, and adults living with #Type1Diabetes, learning their stories and experiences, and engaging in thoughtful conversations about innovation in #DiabetesCare. Check out some highlights below! Thank you to Children with Diabetes for creating such a meaningful space for connection and collaboration. Until next year! #FriendsForLifeOrlando2025 #FFLOrlando2025 #ChildrenWithDiabetes #CWDiabetes #T1D

We're excited to share that we will be presenting Poster #8234, "Levoketoconazole Use Prior to Adrenalectomy," at the Endocrine Society annual meeting (#ENDO2025)! Join us on Sunday, July 13 from 12-1:30 PM PT to hear our findings as we continue to advance our mission to deliver better outcomes for patients with #CushingsSyndrome. #Hypercortisolism #Endocrinology #RareDisease

We are proud to introduce our Intern Class of 2025! Since joining us in early June, they have been making meaningful contributions across our organization, and their passion, dedication, and active participation reflect our commitment to #Innovation and our shared mission of making a difference in patients’ lives. Meet the team: Shreya Raval – IT Helpdesk Intern Brianna Hagemann – Product Development Formulation Intern Kathryn Roarty – Manufacturing & Science Technology Intern Finley Baskel – Marketing Intern Melissa Tran – Medical Affairs Intern Ryan Lutz – Product Development Formulation Team Madeline Judson – Global Development Clinical Intern Ava Meurer – Marketing Intern Aliki Valdes – Regional Medical Affairs Intern Jenna Micor – Analytical Development Intern Rachael Gu – Data Analyst Intern Lauren Weaver – Medical Operations- Diabetes Camp Intern Sophia DeLuca – Combination Product Device Development Intern Joseph Holecek – Accounting & Finance Intern We’re excited to see everything they’ll do this summer. Welcome! #SummerInternship #CompanyCulture #PurposeDriven #FutureOfMedicine

Heading to the Endocrine Society annual meeting (#ENDO2025)? Don't miss our product theater focused on unmet needs in #CushingsSyndrome. On July 12, 10-11 AM PT, we're hosting an in-depth discussion on the challenges of diagnosis and management and how we're working to change the treatment landscape for patients living with this #Endocrine disorder. Whether you're a clinician, researcher, or advocate, we welcome you to be part of this important conversation! #Hypercortisolism #Endocrinology #RareDisease

Just a reminder - the Endocrine Society annual meeting, #ENDO2025, is almost here and we'll be there! We're looking forward to connecting with the #Endocrinology community and sharing our work focused on #CushingsSyndrome and #Diabetes as we join the conversation that drives meaningful change in endocrine health. If you'll be at ENDO, we'd love to see you! Stop by our booth, say hello, and learn more about what we're working on. #Hypercortisolism #Hypoglycemia

We’re excited to announce our presence at the Endocrine Society annual meeting, #ENDO2025, the premier event for #Endocrinology professionals and innovators. We look forward to connecting with industry leaders, sharing insights in the #Diabetes and #CushingsSyndrome spaces, and showcasing how our therapies are helping redefine patient care in endocrine and metabolic diseases. If you’re attending, come say hello! #Hypercortisolism #Hypoglycemia

We are thrilled to share that we will be attending Children With Diabetes Friends for Life Orlando 2025 July 8-13 in Orlando, FL. This annual event is a beacon of hope and support for children and adults living with #Type1Diabetes, bringing together families, healthcare professionals, and innovators to share knowledge, experiences, and the latest advancements in #DiabetesCare. We are committed to improving the lives of those affected by #Diabetes, and our team is looking forward to connecting with the community, learning from experts, and contributing to the ongoing conversation around better diabetes management and care. If you’re attending, we’d love to connect! Stop by our booth to stay hello. #FriendsForLifeOrlando2025 #FFLOrlando2025 #ChildrenWithDiabetes #CWDiabetes #T1D

Thanks for the memories from the 2025 American Diabetes Association #ADASciSessions! It's been an incredible few days in Chicago. A heartfelt thank you to the conference organizers, speakers, and collaborators, and to the entire #Diabetes community for the engaging conversations, innovative research, and reaffirmation of our commitment to improving outcomes for patients living with this condition. We can't wait until next year – but until then, be sure to check out our website for the latest information about our work in #DiabetesCare: https://bit.ly/3Yz8yly. #Hypoglycemia #Type1Diabetes #T1D #Type2Diabetes #T2D #ADA2025